ArticleNPJ breast cancer2019

Randomized phase-II evaluation of letrozole plus dasatinib in hormone receptor positive metastatic breast cancer patients.

Devchand Paul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.